# IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

> **NCT01549106** · PHASE1 · COMPLETED · sponsor: **SecuraBio** · enrollment: 106 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** IPI-145
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01549106
- **Lead sponsor:** SecuraBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549106, "IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01549106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*